Pancrecarb
FDA Wants Consumers to Report Problems »
"A new consumer-friendly form ( is now available for making reports to MedWatch, the Food and Drug Administration's (FDA) on-line system for collecting information about serious problems with drugs, medical devices and other FDA-"...
Pancrecarb
PANCRECARB®
(pancrelipase) Delayed-Release Capsules, Buffered and Enteric-Coated Microspheres.
DRUG DESCRIPTION
PANCRECARB® (pancrelipase) contain buffered pancreatic enzymes: lipase, amylase and protease, isolated and concentrated from porcine pancreatic glands. The enzyme containing microspheres are coated with a pH sensitive enteric-coating to provide protection against gastric inactivation of the buffer-stabilized enzymes during gastric passage.
EACH PANCRECARB® (pancrelipase) CONTAINS:
| MS-4 | MS-8 | |
| Lipase | 4,000 U.S.P. Units | 8,000 U.S.P. Units |
| Amylase | 25,000 U.S.P. Units | 40,000 U.S.P. Units |
| Protease | 25,000 U.S.P. Units | 45,000 U.S.P. Units |
Inactive ingredients include sodium carbonate, sodium bicarbonate, cellulose acetate phthalate, diethyl phthalate, gelatin, sodium carboxymethyl starch, polyvinylpyrrolidone, talc, ursodiol, and other trace ingredients.
Last reviewed on RxList: 1/20/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Pancrecarb Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
